Original Research
Published on 17 May 2023
Acacetin exerts antitumor effects on gastric cancer by targeting EGFR
in Pharmacology of Anti-Cancer Drugs
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1121643
- 2,877 views
- 5 citations
Type at least 3 characters
2,604 articles
Articles
Original Research
Published on 17 May 2023
Integrated machine learning and bioinformatic analyses used to construct a copper-induced cell death-related classifier for prognosis and immunotherapeutic response of hepatocellular carcinoma patients
in Pharmacology of Anti-Cancer Drugs
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1188725
- 3,238 views
- 4 citations
Original Research
Published on 17 May 2023
The mechanism of vitamin D3 in preventing colorectal cancer through network pharmacology
in Pharmacology of Anti-Cancer Drugs
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1192210
- 3,647 views
- 4 citations
Original Research
Published on 17 May 2023
Cost-effectiveness analysis of toripalimab plus chemotherapy as the first-line treatment in patients with advanced non-small cell lung cancer (NSCLC) without EGFR or ALK driver mutations from the Chinese perspective
in Pharmacology of Anti-Cancer Drugs
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1133085
- 2,380 views
- 2 citations
Original Research
Published on 15 May 2023
A novel cell-based screen identifies chemical entities that reverse the immune-escape phenotype of metastatic tumours
in Pharmacology of Anti-Cancer Drugs
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1119607
- 2,457 views
- 7 citations
Review
Published on 12 May 2023
Research progress of interleukin-15 in cancer immunotherapy
in Pharmacology of Anti-Cancer Drugs
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1184703
- 12,119 views
- 19 citations
Review
Published on 12 May 2023
The role of peroxisome proliferator-activated receptors in the tumor microenvironment, tumor cell metabolism, and anticancer therapy
in Pharmacology of Anti-Cancer Drugs
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1184794
- 4,347 views
- 9 citations
Original Research
Published on 11 May 2023
Effects of adjuvant huaier granule therapy on survival rate of patients with hepatocellular carcinoma
in Pharmacology of Anti-Cancer Drugs
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1163304
- 2,017 views
- 5 citations
Original Research
Published on 11 May 2023
Amino acid modified OCMC-g-Suc-β-CD nanohydrogels carrying lapatinib and ginsenoside Rg1 exhibit high anticancer activity in a zebrafish model
in Pharmacology of Anti-Cancer Drugs
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1149191
- 1,582 views
- 3 citations
Case Report
Published on 11 May 2023
Case report: Apatinib combined with neoadjuvant therapy for primary squamous cell carcinoma of the breast: a case report
in Pharmacology of Anti-Cancer Drugs
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1115422
- 1,070 views
- 1 citation
Original Research
Published on 10 May 2023
Nanosecond pulse effectively ablated hepatocellular carcinoma with alterations in the gut microbiome and serum metabolites
in Pharmacology of Anti-Cancer Drugs
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1163628
- 2,271 views
Review
Published on 10 May 2023
CircRNA-miRNA-VEGFA: an important pathway to regulate cancer pathogenesis
in Pharmacology of Anti-Cancer Drugs
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1049742
- 3,006 views
- 15 citations
Original Research
Published on 10 May 2023
Detection of herpes simplex virus in oral tongue squamous cell carcinoma
in Pharmacology of Anti-Cancer Drugs
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1182152
- 3,299 views
- 4 citations
Editorial
Published on 09 May 2023
Editorial: Epigenetic drugs and therapeutic resistance for epithelial malignancies
in Pharmacology of Anti-Cancer Drugs
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1208518
- 1,489 views
- 4 citations
Original Research
Published on 09 May 2023
Co-delivery of doxorubicin and hydroxychloroquine via chitosan/alginate nanoparticles for blocking autophagy and enhancing chemotherapy in breast cancer therapy
in Pharmacology of Anti-Cancer Drugs
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1176232
- 3,075 views
- 10 citations
Original Research
Published on 09 May 2023
Identification of afatinib-associated ADH1B and potential small-molecule drugs targeting ADH1B for hepatocellular carcinoma
in Pharmacology of Anti-Cancer Drugs
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1166454
- 2,667 views
- 2 citations